HIV, human herpesvirus 8, and cancer

$0Z01FY2005CPNIH

Cancer Epidemiology And Genetics

Investigators

Linked publications & trials

Paper 23079809 Paper 22796240 Paper 22729152 Paper 22472857 Paper 22068287 Paper 20921544 Paper 20859116 Paper 20837717 Paper 20825305 Paper 20733533 Paper 20551958 Paper 20337924 Paper 20009763 Paper 19810095 Paper 19777527 Paper 19725826 Paper 19551862 Paper 19434731 Paper 19365835 Paper 19337058 Paper 19317752 Paper 19190628 Paper 19114864 Paper 19064561 Paper 19064559 Paper 19058197 Paper 18957521 Paper 18813102 Paper 18767045 Paper 18580342 Paper 18435450 Paper 18402527 Paper 18301068 Paper 18301061 Paper 18234418 Paper 18224690 Paper 18201267 Paper 18083545 Paper 17855703 Paper 17596594 Paper 17565153 Paper 17554710 Paper 17548695 Paper 17337646 Paper 17197812 Paper 17097130 Paper 17082317 Paper 16936558 Paper 16917006 Paper 16868538 Paper 16868446 Paper 16586362 Paper 16549832 Paper 16537714 Paper 16449994 Paper 16388490 Paper 16106415 Paper 15980688 Paper 15769998 Paper 15150553 Paper 11023486 Paper 10839667 Paper 10836758 Paper 10823754

Abstract

People infected with HIV are at increased risk of cancer, due to AIDS-related immunosuppression, infections with other oncogenic viruses, and other exposures, such as tobacco and alcohol. This project inlcudes studies to examine cancer risk in HIV-infected persons and characterize risk factors for these infections. The project includes studies focusing on Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer (the three AIDS-defining cancers), as well as lung cancer, liver cancer, anal cancer, and Hodgkin lymphoma. The project also includes studies of cancer cofactors of importance to people with HIV/AIDS, including human herpesvirus 8, the causative agent of Kaposi sarcoma. Several studies evaluate cancer risk in Africa, a region heavily affected by the HIV/AIDS epidemic.

View original record on NIH RePORTER →